What are the challenges in developing bacteriophage-based industrial applications?

Phage applications face unique development challenges. Therapeutic development: narrow host range requiring phage cocktails, resistance development necessitating phage rotation/combinations, regulatory pathway uncertainty (drug vs biological), manufacturing scale-up (host strain availability, purification complexity), and stability during storage. Quality considerations: ensuring phage purity (no bacterial debris, endotoxin), titer standardization, activity verification, and absence of transducing particles carrying host genes. Agricultural/food applications: GRAS determinations, application method optimization, and environmental persistence. Industrial biocontrol (preventing contamination): phage-resistant production strain development, application timing optimization, and phage propagation economics. Regulatory frameworks: FDA has approved some phage products; regulatory pathways continue evolving. Precision engineering (phage display, phage-mediated delivery) leverages phage biology for non-therapeutic applications.